William Faloon

Urinary tract infections (UTIs) are among the most common infections seen in American physicians' offices, mostly in women, with approximately 10 millionvisits annually.

Prompt treatment can shorten the duration of symptoms.¹

In a Swedish observational study of women with uncomplicated UTIs, the median duration of symptoms from the time of consultation was about 4 days with antibiotic treatment compared to approximately 6.5 days without treatment. Longer symptom duration was associated with individuals over 50 years old.¹

Physicians are placing greater emphasis on prevention, in part because antibiotic-resistant bacteria have increased over time.²

Most uncomplicated UTIs carry a low risk of serious complications and respond well to first-line antibiotics.³

An estimated 8% to 25% of patients, however, do not improve as expected.^3,4 In many cases, the prescribed antibiotic may be ineffective because the infecting bacteria are resistant to it.⁵

As a result, effective preventive strategies are becoming increasingly important for individuals at elevated risk of recurrent UTIs.

Cranberries have demonstrated the ability to support urinary tract health by helping to prevent bacteria, such as Escherichia coli (E. coli), from adhering to cells lining the urinary tract.⁶

Another promising approach may involve harnessing bacteriophages that target and destroy harmful bacteria while leaving human cells unharmed.⁷

Scientists explored bacteriophages as antibacterial agents long before the discovery of antibiotics. Interest waned after antibiotics became widely available. Today, the rise of antibiotic resistance has renewed scientific attention on bacterio-phages as a potential tool for combating bacterial infections.⁷

The article on page 34 examines research on cranberry powder and bacteriophages. Together, these two approaches may offer a novel strategy for reducing the risk of recurrent UTIs.

For longer life,

William Faloon, Co-Founder, Life Extension®

A Faster UTI Test May Soon Be Available

One way to combat antibiotic resistance is through rapid diagnostic testing that identifies the infecting bacteria and helps determine the most effective antibiotic treatment.

For many otherwise healthy women with typical symptoms, urine culture and antibiotic susceptibility testing are not routinely performed and are generally reserved for recurrent infections, treatment failure, suspected resistance, or atypical presentations.⁸ Patients who are candidates for testing typically must wait two to four days for the lab results that identify the best antibiotics.⁹

Researchers from the University of Reading, the University of Southampton, and Hampshire Hospitals NHS Foundation Trust have developed a new testing approach that can detect bacteria in the urine and determine antibiotic susceptibility within about six hours, rather than the several days required by conventional methods.¹⁰

When compared to standard laboratory methods, this new test matched results in about 97% of cases across seven different antibiotics for UTIs.¹⁰

If successfully validated and adopted in clinical practice, rapid tests such as this could help more patients receive the most appropriate antibiotic from the outset, reducing treatment failures and limiting unnecessary antibiotic exposure.

This new test could play an important role in slowing down the development of antibiotic resistance. However, additional validation studies and regulatory review will likely be required before this test becomes widely available.

Taking alpha-galactosidase with these foods significantly reduced bloating and overall digestive symptoms compared with placebo.⁴⁹

In addition to minimizing digestive discomfort, preclinical evidence suggests that improving enzymatic breakdown of plant foods may also help release nutrients bound within fiber.⁷

References

1. Kornfalt Isberg H, Hedin K, Melander E, et al. Uncomplicated urinary tract infection in primary health care: presentation and clinical outcome. Infect Dis (Lond). 2021 Feb;53(2):94-101.
2. Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2024 Nov 4;7(11):e2444495.
3. Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014 Oct 22-29;312(16):1677-84.
4. Llor C, Monfa R, Garcia-Sangenis A, et al. Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial. Lancet. 2026 Apr 25;407(10539):1603-13.
5. Sanchez GV, Babiker A, Master RN, et al. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012. Antimicrob Agents Chemother. 2016 May;60(5):2680-3.
6. Williams G, Stothart CI, Hahn D, et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023 Nov 10;11(11):CD001321.
7. Ibrahim R, Aranjani JM, Kalikot Valappil V, et al. Unveiling the potential bacteriophage therapy: a systematic review. Future Sci OA. 2025 Dec;11(1):2468114.
8. Kurotschka PK, Gagyor I, Ebell MH. Acute Uncomplicated UTIs in Adults: Rapid Evidence Review. Am Fam Physician. 2024 Feb;109(2):167-74.
9. Available at: https://www.labcorp.com/tests/008847/urine-culture-routine. Accessed September 3, 2026.
10. Needs SH, Lam H, Hayward JE, et al. Accuracy of rapid microcapillary direct antibiotic susceptibility testing for urine samples collected with bacteriostatic boric acid from patients with suspected urinary tract infection. JAC Antimicrob Resist. 2026 Apr;8(2):dlag035.